Lv1
10 积分 2026-05-12 加入
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
2天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
3个月前
已完结
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
3个月前
已完结